Press Releases
Oramed Granted European Patent For Combination Oral Insulin And Glp-1 Analog Capsule
Oramed Pharmaceuticals Inc (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced that the European Patent Office has granted the Company a patent titled, “Methods and Compositions for Treating Diabetes: ...
Press Releases
Food Processors Get a 360-Degree View of Line Performance with Mettler-Toledo’s ProdX 2.0
To supportglobal food manufacturers in meeting the documentation and active managerial control requirements of the Food Safety Modernisation Act (FSMA). When exporting their products to the US,Mettler-Toledo Product Inspection has launched the enhanced ProdX™ 2.0 data...
Press Releases
DiscoverX Partners with B’SYS GmbH to Expand SAFETYscan In Vitro Pharmacological Profiling Services
DiscoverX Corporation, the leading supplier of innovative cell-based assays and services for drug discovery and development announced their partnership with B’SYS GmbH to expand DiscoverX’s SAFETYscan in vitro pharmacological profiling services for ion channel assays. SAFETYscan services provide...
Press Releases
Eyevensys receives French regulatory approval to advance EyeCET platform
Eyevensys, a private biotechnology company developing its proprietary EyeCET platform, the first non-viral gene expression technology that enables the safe, local, sustained production of therapeutic proteins in the eye to address a wide range of ophthalmic diseases. ...
Press Releases
Imanova Receives £1M Award from the MRC To Develop Early Markers of Dementia – the MIND-MAPS Study
Following a £0.5m Medical Research Council (MRC) grant to implement new Positron Emission Tomography (PET) imaging tracers for mitochondrial dysfunction and synaptic loss. Imanova has been awarded an additional £1m of strategic funding from the MRC...
Press Releases
Hardware+Tools Middle East firmly set on growth path
Hardware Tools Middle East looks ahead to a successful 2017 edition, with interest from hardware and tools manufacturers continuing, as market sentiments begin to stabilise across the region. Despite signs of slowing demand in other regions,...
Press Releases
AstraZeneca’s Tagrisso gains full FDA approval for lung cancer
AstraZeneca announced that the US FDA has granted full approval for Tagrisso (osimertinib) 80mg once-daily tablets, for the treatment of patients with metastatic EGFR T790M mutation-positive non-small cell lung cancer (NSCLC), as detected by an FDA-approved test, whose disease...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read